BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Gland Pharma Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
543245
ISIN Demat
INE068V01023
Book Value (Rs)
592.0923532
NSE Symbol
GLAND
Divident Yield %
0.92
Market Cap
(Rs In Cr.)
32,132
P/E (TTM)
28.28
EPS (TTM)
68.96
Face Value
(Rs)
1
Back
Gland Pharma consolidated net profit rises 49.89% in the June 2025 quarter
05-Aug-25   Hrs IST

Net profit of Gland Pharma rose 49.89% to Rs 215.48 crore in the quarter ended June 2025 as against Rs 143.76 crore during the previous quarter ended June 2024. Sales rose 7.41% to Rs 1505.62 crore in the quarter ended June 2025 as against Rs 1401.71 crore during the previous quarter ended June 2024.

ParticularsQuarter Ended
Jun. 2025Jun. 2024% Var.
Sales1505.621401.71 7
OPM %24.4318.86 -
PBDT413.79310.21 33
PBT312.74218.25 43
NP215.48143.76 50

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)